✨ Medicine Approvals
4 OCTOBER
NEW ZEALAND GAZETTE
3463
Manufacturer(s):
Roche Products Limited, T/A Roche Consumer Health, Welwyn Garden City, Hertfordshire, United Kingdom
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 0.8mg equivalent to 0.5mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma AG., Basel, Switzerland
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 1.6mg equivalent to 1mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 2.4mg equivalent to 1.5mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Farmaceutica SA, Barbera del Valles, Barcelona, Spain
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 4.8mg equivalent to 3mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Farmaceutica SA, Barbera del Valles, Barcelona, Spain
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 7.2mg equivalent to 4.5mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Farmaceutica SA, Barbera del Valles, Barcelona, Spain
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Exelon
Active Ingredient(s):
Rivastigmine hydrogen tartrate 9.6mg equivalent to 6mg rivastigmine
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Farmaceutica SA, Barbera del Valles, Barcelona, Spain
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Ospexin
Active Ingredient(s):
Cephalexin (monohydrate) 27.602mg/mL equivalent to 25mg/mL cephalexin
Dosage Form:
Granules for oral suspension
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Biochemie GmbH, Kundl, Austria
Product:
Ospexin
Active Ingredient(s):
Cephalexin (monohydrate) 55.206mg/mL equivalent to 50mg/mL cephalexin
Dosage Form:
Granules for oral suspension
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Biochemie GmbH, Kundl, Austria
Product:
Razene
Active Ingredient(s):
Cetirizine hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Gerard Laboratories, Dublin, Ireland
Product:
Seroquel
Active Ingredient(s):
Quetiapine fumarate 172.69mg equivalent to 150mg quetiapine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer(s):
AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Product:
Seroquel
Active Ingredient(s):
Quetiapine fumarate 345.39mg equivalent to 300mg quetiapine
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 135
Gazette.govt.nz —
NZ Gazette 2001, No 135
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines Act, New Medicines, Exelon, Roche Products
🏥 Medicine Approval: Exelon Capsules
🏥 Health & Social WelfareMedicines Act, Exelon, Rivastigmine hydrogen tartrate, Capsule, Novartis
🏥 Medicine Approval: Ospexin Granules
🏥 Health & Social WelfareMedicines Act, Ospexin, Cephalexin, Granules for oral suspension, Novartis
🏥 Medicine Approval: Razene Tablets
🏥 Health & Social WelfareMedicines Act, Razene, Cetirizine hydrochloride, Film coated tablet, Pacific Pharmaceuticals
🏥 Medicine Approval: Seroquel Tablets
🏥 Health & Social WelfareMedicines Act, Seroquel, Quetiapine fumarate, Film coated tablet, AstraZeneca